Prof. Paolo Gontero reviews risk stratification for Non-Muscle Invasive Bladder Cancer
Generally speaking, while NMIBCs have a more favourable prognosis compared to their MI counterpart, they are not the same and seem to behave differently (i.e. some are relatively indolent, others have aggressive features).
In this episode, Prof. Paolo Gontero (IT) explains why this is the case. He will also discuss the following:
- What is the current, best-recommended way for risk stratification of NMIBCs?
- Is there a way to predict the risk of recurrence of an NMIBC?
- How to tailor treatment recommendations
Prof. Paolo Gontero is a member of the EAU Guidelines panel for Non-Muscle Invasive Bladder Cancer
For more EAU podcasts, please go to your favourite podcast app and subscribe to our podcast channel for regular updates.
Contact our organiser